Role of obesity in the surgical management of advanced-stage ovarian cancer

Adam J. Wolfberg, Fredrick J. Montz, Robert E. Bristow

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To assess whether obese women with advanced-stage ovarian cancer undergoing primary cytoreduction surgery were at increased risk of suboptimal cytoreduction and complications during the operative and postoperative period as compared to nonobese women. STUDY DESIGN: A retrospective, case-control study of all cases of advanced-stage epithelial ovarian cancer managed surgically at Johns Hopkins Hospital between January 1, 1990, and December 31, 1999. RESULTS: Obese patients were as likely as nonobese patients to undergo optimal cytoreduction at surgery. Obese patients were more likely than nonobese patients to be high-risk anesthesia candidates and more likely than nonobese patients to have tumors > 20 cm at surgery. Obese patients were not at greater risk of surgical or postoperative complications than were nonobese patients. CONCLUSION: Obesity is not a risk factor for suboptimal surgical management of advanced-stage ovarian cancer.

Original languageEnglish (US)
Pages (from-to)473-476
Number of pages4
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume49
Issue number6
StatePublished - Jun 1 2004

Keywords

  • Cytoreduction surgery
  • Obesity
  • Ovarian cancer

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Role of obesity in the surgical management of advanced-stage ovarian cancer'. Together they form a unique fingerprint.

  • Cite this